Dr. Chryso Pefkaros Katsoufis, MD

Dr. Katsoufis practices at Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County.

Dr. Katsoufis' NPI, 1154523348, was assigned on June 1, 2007. Dr. Katsoufis graduated from University of Miami, Miller School of Medicine in 2006. Dr. Katsoufis holds Florida license ME104652.

Dr. Katsoufis' primary practice is Jackson Memorial Hospital, at 1611 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 585-1111.

Dr. Katsoufis' primary practice is Jackson Memorial Hospital in Miami, Florida, part of Miami-Dade County. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Katsoufis to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katsoufis practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatric nephrology is Dr. Katsoufis' primary specialty in the NPI Registry, under taxonomy code 2080P0210X. Dr. Katsoufis is board certified in pediatric nephrology by the American Board of Pediatrics. Dr. Katsoufis is licensed in Florida.

CMS data shows 56 Medicare services from Dr. Katsoufis across 1 procedure code in 2024, for 18 Medicare patients. Medicare paid $5,450 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 18 Medicare patients who saw Dr. Katsoufis in 2024. The largest group is under 65, with 18 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 6.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katsoufis' median patient age at 15, with 48% women.

In 2024, Dr. Katsoufis wrote 53 Medicare Part D claims. 89% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $426 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Katsoufis for performance year 2024, reported as part of a group. Dr. Katsoufis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 38 papers to Dr. Katsoufis, published from 2011 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Kidney Failure, Chronic, Renal Dialysis and Acute Kidney Injury. Dr. Katsoufis has published most often in Front Pediatr. Dr. Katsoufis' most frequent co-authors are Wacharee Seeherunvong, MD, Carolyn L. Abitbol, MD and Marissa J. Defreitas, MD.

Dmand AI links Dr. Katsoufis to 1 clinical trial. Conditions studied include Kidney Failure, Chronic and Renal Insufficiency, Chronic.

CMS Open Payments shows 27 general payments to Dr. Katsoufis from 7 drug and device companies from 2016 to 2020. Honoraria make up the largest share, 31% of the total. Fresenius USA Marketing, Inc. paid the most, $3,664.

Dr. Katsoufis graduated from University of Miami, Miller School of Medicine in 2006.

Dr. Katsoufis is in network with 9 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.